Publications

Journal Article Comment Epublish

PubMed: 40693265 DOI: 10.3389/fphar.2025.1625961

Commentary: Anti-TNFα in inflammatory bowel disease: from originators to biosimilars.

Front Pharmacol 16:1625961

Authors: Yingjie Liu, Keying Wang, Wenjiang Wu

Affiliations

  • Shenzhen Hospital (Futian) of Guangzhou University of Chinese Medicine, Shenzhen, China.

MeSH

Inflammatory Bowel Diseases, Biosimilar Pharmaceuticals